Keywords: driven, avastin, ovarian, cancer, market, set, reach

Driven by Avastin, ovarian cancer market set to reach $1.6B by 2016

Article | 10 December 2007

Print This

The 2010 launch of Genentech/Roche/Chugai's Avastin (bevacizumab) for the treatment of ovarian cancer will drive the drug market to ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in